A 6-month open label, flexible-dosage study to assess the safety and effectiveness of Provigil (modafinil) treatment in children and adolescents with excessive sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea syndrome

Trial Profile

A 6-month open label, flexible-dosage study to assess the safety and effectiveness of Provigil (modafinil) treatment in children and adolescents with excessive sleepiness associated with narcolepsy or obstructive sleep apnea/hypopnea syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 30 May 2012

At a glance

  • Drugs Modafinil (Primary)
  • Indications Hypersomnia; Narcolepsy
  • Focus Adverse reactions
  • Sponsors Cephalon
  • Most Recent Events

    • 30 May 2012 Actual patient number is 92 as reported by ClinicalTrials.gov.
    • 30 May 2012 Company added in association field as reported by ClinicalTrials.gov.
    • 30 May 2012 Additional trial location (USA) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top